Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > Why AcuVid is Still Very Much in the Running
View:
Post by Smokey1958 on Apr 08, 2021 10:51am

Why AcuVid is Still Very Much in the Running

These are very recent articles expressing the need for mass testing and the limitations of the Rapid Antigen devices thus far. Definitely worth a glance if you have a few minutes. The last one is a slog, if you're not a biologist but I include it because it is published by The Lancet, one of the most reputable medical journals on the planet.

Enjoy,

Smokey

[/url

https://calgaryherald.com/opinion/columnists/breakenridge-why-have-we-still-not-played-the-rapid-testing-card-in-canada

https://www.inquirer.com/health/coronavirus/rapid-covid-testing-fda-antigen-screening-20210405.html

https://www.cbc.ca/news/canada/toronto/ontario-rapid-covid-tests-third-wave-1.5976001

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00056-2/fulltext

Comment by trinimetal on Apr 08, 2021 6:39pm
The Lancet I once respected. They produced false data on Hydroxychloroquine saying it causes heart complications so  a vaccine can then be made. In order for a vaccine to be made for a specific disease there must be no alternative therapy. When other medical researchers pointed out the misinformation they retracted the report.
Comment by PCGuy10 on Apr 08, 2021 9:53pm
Well Hydroxychloroquine worked well in Donald Trump didn't it? He swore by it and look what happened!
Comment by TraderKSC on Apr 09, 2021 6:05am
LOL, yes "what happened". LOL, he's more stupid than ever, after taken it. ;-)
Comment by spygate on Apr 09, 2021 9:37am
why what happened? I thought he got the virus and recovered...did something else happen that only you know? and what exactly does that have to do with Therma?
Comment by Smokey1958 on Apr 08, 2021 11:47pm
The Lancet doesn't produce research (data) they are a journal that publishes research papers written on any number of medical topics. As far as the malaria drug ....actually I can't even seriously respond to that.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities